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Restless legs syndrome (RLS) is a neurological disorder that entails an urge to move with
a circadian pattern during the evening/night. RLS may be accompanied by decreased
sleep time and increased occurrence of periodic leg movements during sleep (PLMS),
which involve bursts of tibialis anterior (TA) muscle electromyogram (EMG). Mild hypoxia
and non-anemic iron deficiency, a highly prevalent nutritional deficiency, are relatively
unexplored factors in RLS pathophysiology. We tested whether mice exposed to mild
hypoxia, alone or in combination with non-anemic iron deficiency, show decreased
sleep time particularly in the light (rest) period and increased occurrence of TA EMG
phasic events similar to human PLMS. Female C57BL/6J mice were fed diets with
low or normal iron for 6 months from weaning and instrumented with electrodes
to record the electroencephalogram and the EMG of both TA muscles. Mice were
recorded in a whole-body plethysmograph while breathing a normoxic or mildly hypoxic
(15% O2) gas mixture for 48 h. Hypoxia increased minute ventilation during sleep.
The low-iron diet decreased liver and serum iron, leaving blood hemoglobin and
brainstem iron levels unaffected. Hypoxia, either alone or in combination with non-
anemic iron deficiency, decreased non-rapid-eye-movement (non-REM) sleep time, but
this occurred irrespective of the light/dark period and was not associated with increased
occurrence of TA EMG events during non-REM sleep. These results do not support
the hypothesis that mild hypoxia is sufficient to cause signs of RLS, either alone or
in combination with non-anemic iron deficiency, pointing to the necessity of further
susceptibility factors.
Keywords: hypoxia, iron, mice, restless legs syndrome, Willis-Ekbom disease, sleep, circadian, periodic leg
movements during sleep
INTRODUCTION
Restless legs syndrome (RLS) is a chronic neurological disorder that entails the irresistible urge
to move the legs, which occurs after a period of inactivity and improves or disappears with
movement (Wijemanne and Ondo, 2017). The symptoms follow a circadian trend, developing
or worsening in the evening or at night (Hening et al., 1999; Michaud et al., 2005). RLS also
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typically entails objective signs, which include disturbed
nocturnal sleep with decreased sleep time (Hornyak et al.,
2007) and periodic limb movements during sleep (PLMS)
involving repetitive series of phasic increases in tibialis anterior
(TA) electromyogram (EMG) (Montplaisir et al., 1997). The
prevalence of RLS is estimated at 1.9–4.6% with the strictest
criteria, and is about twice as high in women than in
men (Ohayon et al., 2012). RLS decreases the quality of
life to a level similar to other chronic diseases such as
diabetes type 2, depression, and osteoarthritis (Stevens, 2015).
Despite the availability of multiple drug options, long-term
treatment management is often difficult particularly because of
augmentation, a paradoxical increase in symptom severity in the
course of dopamine-agonist therapy (Garcia-Borreguero et al.,
2018). This highlights the unmet need for better long-term
therapies for RLS, which is at least partly due to the uncertainty
that still surrounds RLS pathophysiology.
The relationship between RLS and hypoxia is one of the
most recent and interesting hypotheses on RLS pathophysiology.
An almost threefold prevalence of RLS occurs in patients with
chronic obstructive pulmonary disease compared to age- and sex-
matched control subjects (Lo Coco et al., 2009), and symptoms
of RLS are more prevalent among women at high risk for
obstructive sleep apnea than in women at low risk (Kapsimalis
and Kryger, 2009). On the other hand, patients with RLS
show greater capillary tortuosity in TA muscles than control
subjects, suggesting a role of hypoxia as a factor causing capillary
remodeling (Larsson et al., 2007). Accordingly, transcutaneous
oxygen pressure is lower in patients with RLS than in healthy
subjects in the legs, but not in the trunk (Salminen et al., 2014).
In different geographic areas, RLS prevalence increases in subjects
living at 1800–2800 m above sea level (Sevim et al., 2003; Castillo
et al., 2006; Gupta et al., 2017). At these altitudes, the low
barometric pressure may cause mild hypoxic hypoxia comparable
to that experienced by passengers on commercial aircraft flights,
or to that caused by reducing the inspired O2 fraction from 21 to
15% at sea level (Nicholson and Sznajder, 2014). It is still unclear
whether such mild levels of hypoxia may be causal in triggering
RLS, either per se or in combination with other susceptibility
factors.
Different lines of evidence suggest that iron deficiency is a
susceptibility factor for RLS, possibly in connection with changes
in mitochondrial biogenesis and/or in the expression of HIF, the
hypoxia inducible factor (Earley et al., 2014; Connor et al., 2017).
Conditions of iron deficiency severe enough to cause anemia
are strongly associated with RLS (Trenkwalder et al., 2016), but
do not account for the large prevalence of RLS in the general
population. Milder conditions of non-anemic iron deficiency are
estimated to be much more prevalent (Zimmermann and Hurrell,
2007), but their clinical relevance in general and for RLS in
particular is still poorly understood. Nonetheless, non-anemic
iron deficiency causes symptoms of fatigue that are lessened by
iron supplementation (Houston et al., 2018), and exaggerates
pulmonary vasoconstriction in conditions of mild hypoxia (Frise
et al., 2016). Non-anemic iron deficiency may thus represent
a highly prevalent susceptibility factor for RLS, particularly in
combination with mild hypoxia.
Here, we aimed for a proof of principle that mild hypoxia plays
a causal role in promoting RLS, either per se or in combination
with non-anemic iron deficiency. We performed our experiments
on an animal model (female C57BL/6J mice) in order to achieve
the full experimental control needed for causal inferences, and
because establishing an animal model would accelerate the
search of novel druggable pathways of RLS pathophysiology.
RLS diagnosis is based on subjective symptoms (Wijemanne
and Ondo, 2017), which are hardly amenable to translation on
animal models. We thus focused on the objective signs in mice
that would be consistent with those commonly associated with
RLS in patients: a reduction in sleep time with a characteristic
circadian pattern of prevalence during the light (rest) period and
an increased occurrence of phasic TA EMG events during sleep,
with features similar to those of human PLMS (Montplaisir et al.,
1997; Hening et al., 1999; Michaud et al., 2005; Hornyak et al.,
2007).
MATERIALS AND METHODS
Ethics Statement
The study protocol complied with the EU Directive 2010/63/EU
for animal experiments and with Italian law (DL 26, March 4,
2014) and was approved by the animal welfare committee at the
University of Bologna, Italy, and by the Italian Ministry of Health
(protocol n. 245/2015-PR). All efforts were made to minimize
animal suffering.
Mice
Experiments were performed on 22 female wild-type mice of
the C57BL/6J strain. Mice were bred from a colony expanded
at the Department of Biomedical and Neuromotor Sciences of
the University of Bologna, Italy, from founder mice bought from
Charles River Italy (Calco, Italy). Mice were housed under a
12:12-h light–dark cycle with lights on (i.e., Zeitgeber Time 0, ZT
0) at 9 am, ambient temperature set at 21–23◦C, and free access
to water and food. Breeders were administered a standard rodent
diet (4RF21; Mucedola, Settimo Milanese, Italy).
Dietary Treatment
At weaning, which occurred at 3.7 ± 0.1 weeks of age, female
mice were randomly allocated into two groups, which were
fed either a low-iron rodent diet (iron deficient group, ID;
EF/RM pelleted diet with <9 ppm iron; ssniff Spezialdiäten
GmbH, Soest, Germany) or a nutrient-balanced control diet with
iron supplementation (control group, Ctrl; E15510-04 diet with
179 ppm iron; ssniff Spezialdiäten GmbH). Thereafter, each diet
was provided ad libitum until the termination of the experimental
protocol, which occurred after 24.1 ± 0.6 weeks at euthanasia
after the completion of recordings.
Surgery
Mice underwent surgery at the age of 25–26 weeks
for the implantation of screw electrodes to record the
electroencephalogram (EEG, fronto-parietal differential
lead) and of a couple of wire electrodes in each TA muscle
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to record the EMG, as previously described in detail (Silvani
et al., 2015). The free ends of the TA EMG electrodes were
tunneled subcutaneously to the mouse head. All electrodes were
connected to a miniature custom-built socket (701-9925 RS
Components, Cinisello Balsamo, Italy), which was cemented
to the skull with stainless-steel anchor screws (Plastics One,
Roanoke, VA, United States), dental cement (Rely X ARC,
3M ESPE, Segrate, Italy), and dental acrylic (Respal NF, SPD,
Mulazzano, Italy). At the end of surgery, mice were administered
benzathine penicillin (3750 UI/mouse) and dihydrostreptomycin
sulfate (1.5 mg/mouse) in 800 µL saline subcutaneously to
prevent infections and dehydration. All surgical procedures
were performed under isoflurane anesthesia (1.8–2.4% in O2,
inhalation route) with intra-operative analgesia (Carprofen
0.1 mg subcutaneously, Pfizer Italy, Latina) on a heating pad to
prevent mouse hypothermia. A 1 week’s recovery from surgery
was allowed before the start of the recordings procedures.
Experimental Protocol
Upon completion of postoperative recovery, mice were
connected to a lightweight cable for transmission of EEG and
TA EMG signals. The experimental schedule was performed
on four consecutive days. On days 1 and 2, the mice were
continuously exposed to a normoxic gas mixture (21% O2 in N2)
during a 24 h period (day 1) of habituation to the experimental
apparatus and a subsequent 24 h period (day 2) of recordings.
Then, on days 3 and 4, the same procedures as in the previous
2 days were repeated with continuous exposure to a hypoxic gas
mixture (15% O2 in N2). Transitions from the habituation to the
recordings environment were performed at ZT 3.
At the end of the recording session in conditions of hypoxia,
mice were euthanized by anesthetic overdose (isoflurane 4% in
O2) for harvesting of blood, brainstem, and liver samples, and
autopsied. Liver samples weighting 60–90 mg were dissected
taking care to avoid including major blood vessels and the
gallbladder. An aliquot of whole blood was heparinized to
prevent clotting and stored at −80◦C for subsequent analysis
of hemoglobin concentration, together with the brain and liver
samples. Another aliquot of blood was centrifuged at 3000 rpm
for 15 min at ambient temperature to obtain the serum, which
was stored at −80◦C for subsequent measurement of iron
concentration. Sterile test tubes were employed for sample
storage.
Recordings
Simultaneous recordings of EEG, bilateral TA EMG, and
breathing were performed as previously described in detail
(Silvani et al., 2014) inside a modified 2-chamber whole-
body plethysmograph (PLY4223, Buxco, Wilmington, NC,
United States) consisting of a mouse chamber and a reference
chamber. The mouse chamber was modified to decrease its
internal volume to 0.97 L and to house a rotating electrical swivel
(SL6C/SB, Plastics One) to prevent twisting of the mouse wire
tether, and probes to measure temperature and humidity (PC52-
4-SX-T3 sensor, Rense Instruments, Rowley, MA, United States).
The whole-body plethysmograph was calibrated dynamically
with a 100µL micro-syringe (Hamilton, Reno, NV, United States)
at the termination of each recording session. Habituation was
performed inside a dummy whole-body plethysmograph with
the same base area and made of the same material as the actual
plethysmograph, equipped with a rotating dummy swivel. The
true and dummy plethysmographs were continuously flushed
with 1.5 L/min of normoxic or hypoxic gas mixtures, depending
on the experimental session, in order to prevent buildup of CO2
and humidity. Food (low-iron or control diet depending on the
group) and water were always provided ad libitum.
The EEG and EMG signals were acquired via wire
transmission, amplified, and filtered (EEG, 0.3–100 Hz; EMG,
10–1000 Hz) using 7P511J amplifiers (Grass, West Warwick,
RI, United States). The differential pressure between the mouse
chamber and the reference chamber was measured with a high-
precision pressure transducer (DP103-06, Validyne Engineering,
Northridge, CA, United States), and digitized, together with the
signals of EEG, EMG, and mouse chamber temperature and
humidity, at 16-bit and 1024 Hz with a PCI-6224 board (National
Instruments, Austin, TX, United States) operated by software
written in the laboratory using Labview (National Instruments).
Sleep Scoring
The states of wakefulness, non-rapid-eye-movement (non-REM)
sleep, and REM sleep were scored with a 4-s time resolution
based on qualitative visual inspection of the EEG signal and of
the frequency, amplitude, and baseline value of raw respiratory
recordings, as previously described in detail (Bastianini et al.,
2017). Briefly, wakefulness was scored when the EEG was at a low
voltage and included mixed frequencies, and the baseline value
of the respiratory signal was highly irregular due to gross body
movements that caused pressure artifacts obscuring individual
breaths. Non-REM sleep was scored when the EEG was at a
high voltage with prominent δ (0.5–4 Hz) frequency components,
breathing frequency and amplitude were stable and regular,
and the baseline value of the respiratory signal was steady.
REM sleep was scored when the EEG was at a low voltage
with predominant θ (6–9 Hz) frequency components, breathing
frequency and amplitude were irregular, and the baseline value
of the respiratory signal was steady. Scoring of all tracings was
performed by a single researcher (SB) highly trained in this
procedure for maximal accuracy. The percentages of recording
time spent in wakefulness, non-REM sleep and REM sleep were
eventually averaged over 3-h time bin and analyzed as a function
of hypoxia/normoxia, low/normal dietary iron, and ZT.
Quantitative Analysis of Breathing During
Non-REM Sleep and REM Sleep
The values of ventilatory period (i.e., the interval between
successive breaths, TTOT), tidal volume (VT) per gram body
weight, and minute ventilation (i.e., VT/TTOT) per gram body
weight were computed on non-REM and REM sleep episodes
lasting ≥12 s (i.e., at least 3 consecutive 4-s epochs) as
previously described in detail (Silvani et al., 2014). Breaths were
identified automatically from the upward (+) deflection peak of
plethysmograph pressure. Errors in breath detection as well as
pressure artifacts (e.g., due to opening and closing of the room
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door) were manually excluded from the analyses. The analysis
was not performed during wakefulness, when, as mentioned
above, the marked irregularity of respiratory signal baseline often
obscured individual breaths. The values of minute ventilation,
VT, and TTOT were eventually averaged over all recorded episodes
of non-REM sleep and REM sleep and analyzed as a function of
hypoxia/normoxia, low/normal dietary iron, and sleep state.
Quantitative Analysis of TA EMG Bursts
During Non-REM Sleep
The TA EMG bursts were scored and analyzed with a two-
step semi-automated procedure during non-REM sleep as
previously described in detail (Silvani et al., 2015). In the
present study, the isolated 4-s epochs scored as wakefulness that
were preceded and followed by non-REM sleep epochs were
treated as non-REM sleep for the purpose of the TA EMG
burst analysis. This was meant to avoid excluding the largest
brief TA EMG bursts during non-REM sleep, which may cause
irregularities of the plethysmographic signal baseline scored as
single epochs of wakefulness according to the criteria listed
above.
The first step of the analysis of TA EMG bursts was performed
with an algorithm for automatic scoring, which was previously
validated against consensus visual scoring of TA EMG bursts
in mice, with a sensitivity of 90% and a false positive rate of
31% (Silvani et al., 2015). The second step of TA EMG bursts
analysis consisted of a manual editing of the results of the
automatic scoring based on the raw tracings of TA EMG. This
second step was aimed to detect all phasic motor events that
involved one or both TA muscles, entailed EMG bursts clearly
discernible against the EMG background, and had duration<4 s,
following previously published scoring rules (Silvani et al., 2015).
To maximize accuracy, the TA EMG bursts of all mice were
visually scored by the same researcher highly trained in this
procedure (VLM).
According to previous work (Silvani et al., 2015), the TA
EMG bursts that overlapped to any extent were considered to
represent the same TA EMG event regardless of whether they
occurred in different limbs. The time structure of TA EMG
events was evaluated by computing the intervals between the
onset of consecutive events (inter-event intervals, IEI). The IEI
distribution, i.e., the number of IEI scored per hour of non-
REM sleep grouped in 5-s intervals up to 60 s, was computed
as a function of hypoxia/normoxia, low/normal dietary iron, and
light/dark period. The upper IEI limit of 60 s was chosen in
agreement with a previous study on mice (Silvani et al., 2015) and
corresponds to the recently proposed, data-driven upper limit for
the inter-movement intervals of PLMS in patients with RLS (Ferri
et al., 2018). The occurrence rate of four different categories of TA
EMG events was compared as a function of hypoxia/normoxia,
low/normal dietary iron, and sleep state: (1) all TA EMG events,
regardless of their IEI; (2) short-interval TA EMG events with IEI
between 0.5 and 10 s (Silvani et al., 2015); (3) long-interval TA
EMG events with IEI between 10 and 60 s; (4) long-interval TA
EMG events with IEI between 10 and 60 s organized in series of 4
or more events, which most closely correspond to human PLMS
(Ferri et al., 2018). The 0.5 and 10 s boundaries of short-interval
TA EMG events were chosen in agreement with previous work
on mice, in which the IEI distribution was relatively flat from 10 s
upward (Silvani et al., 2015).
Iron and Hemoglobin Assays
Hemoglobin concentration was measured from whole
blood samples with a colorimetric assay (MAK115, Sigma-
Aldrich; linear detection range: 0.9–200 mg/dL) performed in
quadruplicate following manufacturer’s instructions. Non-heme
iron was measured in the whole brainstem, liver, and serum with
a published colorimetric assay protocol (Rebouche et al., 2004).
Brainstem and liver homogenates were prepared by sonication
in 10:1 (volume/weight) ultrapure water, added to an equal
volume of protein precipitation solution (HCl 1 M and 10% TCA
in ultrapure water), incubated at 95◦C for 1 h to digest tissue
proteins, cooled at room temperature for 2 min, mixed again, and
centrifuged at room temperature at 8200 g for 10 min. Aliquots
of 250 µL supernatant were combined with an equal volume
of chromogen solution (ferrozine 0.508 mM, sodium acetate
1.5 M, and 1% v/v thioglycolic acid in ultrapure water). Dilute
liver samples were also analyzed by mixing 125 µL supernatant
with 62.5 µL of ultrapure water, 62.5 µL of protein precipitation
solution, and 250 µL of working chromogen solution, in case
the assayed iron content of the undiluted samples was beyond
the upper limit (10 µg/mL) of the standard iron concentration
curve (cf. below). For serum measurements, 100 µL serum were
added to 100 µL ultrapure water and 250 µL of chromogen
solution. Samples were prepared in duplicate, each with its
own blank made by 250 µL of tissue extract supernatant and
250 µL of 1.5 M sodium acetate and 1% v/v thioglycolic acid in
ultrapure water, without the addition of ferrozine. After 30 min
incubation at room temperature, absorbance was measured
in semi-micro cuvettes at a wavelength of 562 nm. Standard
concentration/absorbance curves with iron concentrations of 0,
1, 2, 4, 6, 8, and 10 µg/mL (tissue samples) or 0, 0.5, 1, 1.5, 2,
and 2.5 µg/mL (serum samples) were prepared fresh by diluting
different volumes of a 100 µg/mL iron standard in ultrapure
water (Titrisol Standard 1 g/100 mL, diluted 1% v/v in HCl 15%
in high-purity water). Readings were performed in duplicate. The
intra-assay coefficient of variation determined in preliminary
analyses in quintuplicate was 0.9%.
Statistical Analysis
Data were analyzed using SPSS Statistics (IBM Corp., Armonk,
NY, United States) with mixed model analysis of variance
(ANOVA) with Huynh-Feldt correction in case of failure of
the sphericity assumption, and t-tests, with significance at
P < 0.05. Data were shown as means ± SEM with n = 8
per dietary group for the analysis of TA EMG events, and
with n = 11 per dietary group for the analysis of sleep.
The sample size was set a priori with a statistical power
analysis performed with G∗power software1. Calculations based
on mean values and variances of published data on healthy
mice (Silvani et al., 2015) indicated that a sample size of
n = 8 per dietary group allowed a 80 and 95% statistical
1www.gpower.hhu.de
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power to detect a 50% difference in the occurrence rate of
TA-EMG events during non-REM sleep employing independent-
samples and repeated-samples t-tests, respectively. The sample
size for comparisons involving sleep variables was further
increased to n = 11 per group due to the inclusion of
three more mice per dietary group, in which one or both
TA EMG signals were missing because of EMG electrode
failure.
RESULTS
Figure 1 shows representative raw tracings of EEG, bilateral
TA EMG, and breathing obtained inside a whole-body
plethysmograph during wakefulness (A), non-REM sleep
(B) and REM sleep (C). During the recordings, Ctrl and ID mice
weighted 19.3 ± 0.4 g and 20.1 ± 0.5 g, respectively, with a loss
of 8± 2% and 6± 1%, respectively, of the body weight at surgery
(P = 0.366, t-test).
The time spent in wakefulness, non-REM sleep, and REM
sleep is shown in Figure 2 in terms of percentages of total
recording time as a function of hypoxia/normoxia, low/normal
dietary iron, and ZT. As expected, the time spent in each
wake-sleep state significantly depended on ZT (ANOVA main
effect, P < 0.001). In particular, mice spent more time
in wakefulness and less time in non-REM sleep and REM
sleep during the dark period than during the light period
(P < 0.001, t-test), exception made for the 3-h time bin
of the light period around ZT 3. This corresponded to the
start of the recordings, when mice were transferred from
the dummy plethysmograph employed for habituation to the
true plethysmograph. ANOVA main effects indicated that low
dietary iron did not significantly affect the time spent in
any wake-sleep state either in terms of ANOVA main effects
(P ≥ 0.708) or of ANOVA interaction with other factors
(P ≥ 0.214). On the other hand, regardless of iron deficiency,
hypoxia significantly increased wakefulness time (P = 0.030)
and decreased non-REM sleep time (P = 0.034), whereas it did
not modify significantly REM sleep time (P = 0.483). These
effects of hypoxia occurred irrespective of the light/dark period
(P ≥ 0.720).
The values of TTOT, VT per gram body weight, and minute
ventilation per gram body weight are shown in Figure 3 as
a function of hypoxia/normoxia, low/normal dietary iron, and
sleep state. With respect to non-REM sleep, REM sleep entailed
significant decreases both in TTOT and in VT, which resulted in
a slight but significant decrease in minute ventilation. Hypoxia
significantly increased minute ventilation by decreasing TTOT
and by increasing VT (ANOVA main effects: hypoxia, P ≤ 0.006;
sleep state, P ≤ 0.031; iron deficiency, P ≥ 0.269; ANOVA
interactions, P ≥ 0.053).
The IEI distribution during non-REM sleep is shown in
Figure 4 as a function of hypoxia/normoxia, low/normal
dietary iron, and the light/dark period. The IEI distribution
showed a prominent peak for IEI ≤10 s, followed by a longer
tail up to IEI = 60 s. Hypoxia/normoxia, dietary iron, and
light/dark period did not exert any significant effect on the IEI
distribution during non-REM sleep, either individually or in
combination with other factors (ANOVA: main effects, P≥ 0.289;
interactions, P ≥ 0.100). Neither hypoxia nor iron deficiency
modified the general shape of the IEI distribution curve, and
in particular no peak appeared in the range of long IEI
>10 s.
Figure 5 shows the total occurrence rate of TA EMG
events during non-REM sleep, considering all TA EMG events
together (panel A) or, separately, all the TA EMG events that
had IEI ≤10 s (short-IEI TA EMG events, panel B), all the
TA EMG events that had IEI between 10 and 60 s (long-
IEI TA EMG events, panel C), and the long-IEI TA EMG
events included in series of four or more events (“periodic”
TA EMG events, panel D). The occurrence rate of all TA
EMG events (Figure 5A) and that of short-IEI TA EMG events
during non-REM sleep (Figure 5B) did not differ significantly
as a function of hypoxia/normoxia, dietary iron, and the
light/dark period (ANOVA: main effects, P ≥ 0.234; interactions,
P ≥ 0.128). Conversely, the occurrence rate of long-IEI TA
EMG events during non-REM sleep (Figure 5C) depended
significantly on the 3-way interaction among hypoxia/normoxia,
low/normal dietary iron, and the light/dark period (ANOVA,
P = 0.017). However, none of the simple effects of the light/dark
period, hypoxia, and iron deficiency on the occurrence of
long-IEI TA EMG events during non-REM sleep was robust
enough to reach statistical significance (P ≥ 0.368, P ≥ 0.068,
and P ≥ 0.058, respectively; t-test). On the other hand, the
occurrence rate of “periodic” TA EMG events during non-
REM sleep (Figure 5D) significantly depended on the light/dark
period and on its interaction with hypoxia/normoxia (ANOVA;
P = 0.026 and P = 0.019, respectively). In particular, the
occurrence rate of “periodic” TA EMG events was higher
during the light than during the dark period in conditions
of hypoxia, but not in conditions of normoxia (P = 0.010
and P = 0.780, respectively, t-test). The impact of low/normal
dietary iron on “periodic” TA EMG events was not significant,
either in terms of its main effect or of its interactions
with other factors (ANOVA, P = 0.771 and P ≥ 0.076,
respectively).
The iron concentration in serum, liver, and brainstem
and the blood hemoglobin concentration measured on
samples harvested at the termination of the recordings
after hypoxia (cf. methods) are reported in Figure 6. The
low-iron diet caused a significant 38% decrease in serum
iron and 85% decrease in liver iron stores (P = 0.022 and
P < 0.001, respectively; t-test). Conversely, blood hemoglobin
concentration and brainstem iron concentration were not
significantly affected by the low-iron diet (P > 0.650,
t-test).
DISCUSSION
We investigated whether female C57BL/6J mice exposed to
mild hypoxia, alone or in combination with non-anemic iron
deficiency, showed signs consistent with human RLS. We found
that mild hypoxia was sufficient to elicit a significant increase
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FIGURE 1 | Representative raw tracings of the electroencephalogram (EEG), the raw ventilation signal yielded by the whole-body plethysmograph (VENT), and the
left (L) and right (R) electromyogram (EMG) of tibialis anterior (TA) muscles during wakefulness (A), non-rapid-eye-movement (non-REM) sleep (B), and
rapid-eye-movement (REM) sleep (C) in the same iron-deficient mouse in conditions of hypoxia. Scoring of TA EMG bursts (red) was performed only in non-REM
sleep.
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FIGURE 2 | Percentages of recording time spent in wakefulness (A,B),
non-rapid-eye-movement (non-REM) sleep (C,D), and rapid-eye-movement
(REM) sleep (E,F), averaged every 3 h in mice fed control diet (Ctrl) or
iron-deficient diet (ID) during normoxia (black) and hypoxia (red). Zeitgeber
time (ZT) 0 is time at lights on. The gray shading indicates the period with
lights off (dark period). The yellow shading indicates the 3-h bin including ZT
3, when mice were first transferred to the recording environment. Data are
means ± SEM with n = 11 per group. ∗ and †, P < 0.05, main effects of
hypoxia and ZT, respectively (ANOVA).
in minute ventilation during sleep, and that 6 months of low-
iron dietary treatment from weaning were sufficient to decrease
serum and liver iron but not blood hemoglobin and brainstem
iron storage. Mild hypoxia, either alone or in combination with
non-anemic iron deficiency, caused a significant decrease in non-
REM sleep time, irrespectively of the light/dark period. Although
mild hypoxia tended to reorganize the distribution of sleep-
related “periodic” TA EMG events during non-REM sleep, this
was not accompanied by any robust increase in phasic TA EMG
activity or by any significant change in the shape of the IEI
distribution.
In our experiments, the decrease in the O2 fraction from 21
to 15% with a barometric pressure of 760 mm Hg entailed a
decrease in the O2 partial pressure (PO2) from 160 to 114 mm Hg.
A similar PO2 decrease is caused by the decrease in barometric
pressure at approximately 2450 m above sea level. A study in
a Turkish population found higher RLS prevalence in people
living at higher altitudes, taking into account only locations
up to 1800 m (Sevim et al., 2003). Another study on native
South Americans in Ecuador found higher RLS prevalence in
people living at 2816 m altitude than in people living at sea
level (Castillo et al., 2006). A recent study on people living in
the Himalayan and sub-Himalayan regions of India found an
increased RLS prevalence in people living at 1900–2000 m than
in those living at 400 m altitude, with no further increase in
people living at 3200 m above sea level (Gupta et al., 2017).
Taken together, these considerations indicate that the O2 fraction
of the gas mixture breathed by mice in the conditions of mild
hypoxia of the present study was in line with the PO2 in different
high-altitude locations around the world with increased RLS
prevalence (Sevim et al., 2003; Castillo et al., 2006; Gupta et al.,
2017).
Previous experiments performed on male mice with genetic
background and age that were similar, but not identical to those in
our study (hybrid 129/Sv-C57BL/6 mice backcrossed to C57BL/6
for 5 generations, aged 24–36 weeks vs. C57BL/6J mice aged 27–
28 weeks) did not show significant changes in sleep time or in
tidal volume or ventilatory rate during sleep when mice breathed
a 15% O2 hypoxic mixture for 6 h (Nakamura et al., 2007). The
discrepancy with our results may be because of differences in the
sex of the mice or the duration of hypoxia or because of slight
differences in genetic background and age of the mice.
A decrease in non-REM sleep time during the night has
been reported in patients with RLS, together with a decrease
in sleep efficiency and increases in sleep fragmentation and
arousal index, and also with a decrease in REM sleep time
(Hornyak et al., 2007). RLS symptoms have a circadian rhythm
of prevalence during the evening/night (Hening et al., 1999;
Michaud et al., 2005), which corresponds to the beginning of the
light period in mice. On these bases, we reasoned that a reduction
in sleep time restricted to or most evident during the light (rest)
period in our mice would be most consistent with RLS signs
in humans. However, contrary to our hypothesis, the decrease
in non-REM sleep time we found in mice during mild hypoxia
occurred during the light and dark periods irrespective of ZT
(Figure 2).
More than 80% of patients with RLS show more than 5
PLMS per hour of sleep (Montplaisir et al., 1997). The most
recent guidelines of the World Association of Sleep Medicine
(WASM) recommend scoring PLMS as phasic TA EMG events
that comply with a set of criteria that include the length of
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FIGURE 3 | Values of minute ventilation per unit body weight (A), ventilatory period (TTOT, B), and tidal volume per unit body weight (VT, C) during
non-rapid-eye-movement sleep (N) and rapid-eye-movement sleep (R) in mice fed control diet (Ctrl) or iron-deficient diet (ID) during normoxia (black) and hypoxia
(red). Data are means ± SEM with n = 11 per group. ∗ and †, P < 0.05, main effects of hypoxia and sleep state, respectively (ANOVA).
FIGURE 4 | Distribution of the time intervals (inter-event intervals, IEI) between
consecutive tibialis anterior (TA) electromyographic (EMG) events, expressed
as number of IEI per hour of time spent in non-rapid-eye-movement sleep (N),
in mice fed control diet (Ctrl, A,B) or iron-deficient diet (ID, C,D) during
normoxia (black) and hypoxia (red). Data are shown separately for the light
period (A,C) and dark period (gray shading, B,D) as means ± SEM with n = 8
per group. ANOVA did not indicate any significant effects of the light/dark
period, hypoxia/normoxia, and Ctrl/ID group (cf. text for details).
inter-movement intervals (10–90 s) and the number of events
in a series (4 or more) (Ferri et al., 2016). Recent data suggest
decreasing the upper limit of the inter-movement interval of
PLMS to 60 s (Ferri et al., 2018). Adult patients with RLS
FIGURE 5 | Number of different categories of tibialis anterior (TA)
electromyographic (EMG) events per hour of time spent in
non-rapid-eye-movement sleep (N) during the light period (L) and the dark
period (D, gray shading) in mice fed control diet (Ctrl) or iron-deficient diet (ID).
(A) Total number of TA EMG events per hour N time; (B,C) number of TA EMG
events separated by inter-event intervals (IEI) between 0.5 and 10 s (short-IEI
TA EMG events) or between 10 and 60 s (long-IEI TA EMG events),
respectively, per hour N time; (D) number of long-IEI TA EMG events in series
of four or more, expressed per hour N time. Data are means ± SEM with
n = 8 per group. †P < 0.05, L vs. D (t-test).
typically show an increased occurrence rate not only of PLMS,
but also of all leg movements during sleep (LMS) compared
to control subjects (Ferri et al., 2017a). The short-interval LMS
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FIGURE 6 | Values of iron (Fe) concentration measured in serum (A), liver (B),
and brainstem (D) and of blood hemoglobin concentration (C) in the mice fed
control diet (Ctrl) or iron-deficient diet (ID). Data are means ± SEM with
n = 8–11 per group. ∗P < 0.05 vs. Ctrl (t-test).
with inter-movement interval between 0.5 and 10 s entail greater
accompanying changes in heart rate compared with PLMS (Ferri
et al., 2017b). Short-interval LMS also occur in healthy human
subjects, albeit at a much lower rate than in patients with RLS
(Ferri et al., 2017a), as well as in healthy rats and mice (Silvani
et al., 2015). In this study, we confirmed that the distribution of
TA EMG events during non-REM sleep in mice had a prominent
peak for IEI <10 s, corresponding to short-interval LMS, but no
other peak for IEI between 10 and 60 s, which would be consistent
with human PLMS (Figure 4). This distribution was remarkably
stable across the 24-h, without significant differences between
the light period and the dark period. Little is known on the
circadian rhythm of LMS in human subjects. Limited evidence
on four subjects with a high occurrence rate of PLMS but no
RLS suggested a circadian rhythm of PLMS occurrence, which
peaked at the transition between subjective day and night (Duffy
et al., 2011). It is unclear whether this also holds for patients
with RLS (Michaud et al., 2005) and/or for other categories of
LMS, such as the short-interval LMS. It is known, however, that
PLMS occurrence peaks during the second hour of sleep and then
progressively declines throughout the night in patients with RLS
(Ferri et al., 2017a), whereas the occurrence of short-interval LMS
is stable throughout the night (Silvani et al., 2015; Ferri et al.,
2017a).
Despite the absence of a clear-cut peak of the distribution
of TA EMG events during non-REM sleep for IEI >10 s, some
TA EMG events during non-REM sleep satisfied sequence and
IEI criteria similar to those for human PLMS (cf. methods).
We found that the time structure of these “periodic” TA EMG
events was significantly affected by hypoxia, which enhanced a
nychthemeral rhythm with the higher occurrence rate during
the light (rest) period (Figure 5). Nonetheless, the occurrence
rate of these “periodic” TA EMG events during non-REM sleep
was not significantly higher in conditions of hypoxia than in
those of normoxia either in the light or in the dark period.
Similarly, hypoxia did not significantly increase the occurrence
during non-REM sleep of long-interval (10–60 s) TA EMG
events of any sequence length, of short-interval (<10 s) TA
EMG events, or of all TA EMG events regardless of their IEI
(Figure 5). Clearly, these findings are not consistent with the
marked differences in LMS occurrence between adult patients
with RLS and control subjects (Ferri et al., 2017a). Thus,
they do not support the hypothesis that hypoxia increases
the occurrence of TA EMG events during non-REM sleep
in mice. It is worth remarking that an a priori statistical
power analysis estimated an extremely high (95%) power to
detect even a modest 50% difference in the occurrence rate of
TA EMG events during non-REM sleep due to hypoxia (cf.
methods).
In our study, long-term administration of a low-iron diet
to female C57BL/6J mice for 6 months from weaning resulted
in a dramatic 85% depletion of iron stores in the liver,
which is the main iron storage organ (Ganz, 2013), and in
a 38% decrease in serum iron concentration, but did not
result in significant decreases in hemoglobin concentration and
brainstem iron levels (Figure 6). This corresponds to non-anemic
iron deficiency, a condition of iron-deficient erythropoiesis
(Adamson, 2008). This condition did not lead per se to any
significant change in sleep (Figure 2) or TA EMG events during
sleep (Figures 4, 5). Again, it is worth remarking that our
statistical power analysis estimated a 80% power to detect a
50% difference in TA EMG events due to iron deficiency (cf.
methods).
Employing the same low-iron diet as in the present study
but for a shorter period of time (15 weeks vs. 24 weeks), male
C57BL/6J mice were previously reported to develop a 33%
decrease in serum iron concentration, a shift in the light/dark
rhythm of motor activity, with increased voluntary activity (wheel
running) at the end of the active (dark) period, and increased pain
responses, which were claimed to resemble features of patients
with RLS (Dowling et al., 2011). A similar alteration in light/dark
rhythms of non-REM sleep had been previously reported on
male C57BL/6J mice administered a diet with a slightly lower
iron content (6.6 ppm iron) for a much shorter period of time
(6 weeks) (Dean et al., 2006). Neither of these previous studies
(Dean et al., 2006; Dowling et al., 2011) measured hemoglobin
concentration, body iron stores, or brain iron concentration,
which would have helped clarify the reasons for the discrepancy
with our results. On the other hand, both studies (Dean et al.,
2006; Dowling et al., 2011) involved male mice, whereas ours
involved female mice because of evidence that RLS is more
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prevalent in females (Manconi et al., 2012). However, we studied
virgin female mice to decrease experimental variability due to
differences in litter size, whereas previous pregnancies are known
to contribute to gender differences in RLS prevalence (Pantaleo
et al., 2010). It is therefore possible that male mice are more
susceptible than virgin female mice to the sleep and motor
consequences of iron deficiency. Regardless, the face validity
for RLS of increased motor activity (Dowling et al., 2011) and
decreased non-REM sleep (Dean et al., 2006) at the end of the
active period may be questioned, given that that, as previously
remarked, the circadian rhythm of symptoms in patients with
RLS prominently involves the rest period of the day (Hening et al.,
1999; Michaud et al., 2005). A recent study on iron-deficient rats,
which developed a dramatic, approx. 50% decrease in hematocrit,
and a massive, 600–700% increase in PLMS occurrence rate, also
found a peak in the occurrence rate of PLMS and periodic leg
movements during wakefulness (PLMW) in the last hours of the
active period (Lai et al., 2018), but no decrease in sleep during
the last hours of the active period (Lai et al., 2017). Sleep time
during the active period was actually increased in some of the rats
(Lai et al., 2018), which may translate excessive daytime sleepiness
occasionally reported in patients with RLS (Fulda and Wetter,
2007; Kallweit et al., 2009). However, it is actually the lack of
profound sleepiness during daytime in spite of poor nocturnal
sleep that is considered a characteristic finding in most patients
with RLS, and is therefore included as a supporting clinical
features for RLS diagnosis in the updated IRLSSG consensus
criteria (Allen et al., 2014). These differences in the interpretation
of experimental results highlight the lack of consensus on the
optimal experimental readouts for RLS in animal models, given
that RLS is diagnosed entirely based on the subjective symptoms
(Allen et al., 2017).
Taken together, our results do not support the hypothesis that
mild hypoxia is sufficient to elicit the set of explicit, objective
experimental RLS readouts that we employed in this study
on mice. Based on the previous considerations, it is possible
that the objective metrics used in the present study did not
capture the entire spectrum of clinical symptoms that lead to
diagnosis of RLS. Nonetheless, having explicit, objective readouts
is unavoidable for the use of animal models to study RLS.
A limitation of our study design is that for logistical reasons,
we did not study mice raised under hypoxic conditions. This
might explain the discrepancy between our negative findings
and the clinical association between RLS and chronically
hypoxic conditions (Sevim et al., 2003; Castillo et al.,
2006; Kapsimalis and Kryger, 2009; Lo Coco et al., 2009;
Gupta et al., 2017). Nonetheless, our study involved mice
exposed to mild hypoxia for a total of 48 h. This time is
relatively long compared to that employed in other studies
on sleep physiology in mice (Nakamura et al., 2007) and
sufficient to entail changes in brain mitochondrial biogenesis
(Gutsaeva et al., 2008) and brain HIF expression (Shao
et al., 2005), which are thought to underlie causal links
among hypoxia, iron deficiency, and RLS (Connor et al.,
2017).
While it remains conceivable that mild hypoxia requires
additional promoting factors to elicit RLS signs, our data do
not support the hypothesis that non-anemic iron deficiency
is one of these factors. We cannot exclude that more severe
levels of hypoxia alone or in combination with severe, anemic
iron deficiency, may elicit RLS signs in mice. However, these
severe conditions arguably characterize only a small fraction
of the patients with RLS. We also cannot exclude that mild
hypoxia is effective in eliciting RLS signs if iron deficiency
involves the neural tissue. Neural iron deficiency did not occur
in our study (Figure 6), but has been consistently associated
with human RLS (Trenkwalder et al., 2016). We studied mice
of the C57BL/6J strain, which is reportedly the most widely
used inbred strain2. In a study of brain iron concentration
performed on a panel of 24 inbred mouse strains under a low
dietary iron regimen, C57BL/6J mice ranked 12/24 and 20/24 in
terms of decreasing iron concentration in the ventral midbrain
and caudate/putamen, respectively, indicating a median to
high susceptibility of C57BL/6J mice to brain iron deficiency
depending on the brain region (Jellen et al., 2012). Studying
mice at the high end of the genetic spectrum of susceptibility
to brain iron deficiency may be a promising strategy for future
experiments. Nonetheless, the distribution of brain iron estimates
often shows a wide overlap between individuals with and
without RLS (Allen et al., 2001; Rizzo et al., 2013; Li et al.,
2016).
The mechanisms responsible for the differential susceptibility
to RLS in subjects with similar levels of brain iron still remain
unclear. Genetic factors may be at stake, as a recent meta-analysis
of genome-wide association studies highlighted 19 genetic risk
loci for RLS, mainly related to neurodevelopment (Schormair
et al., 2017). Interestingly, at least two of the genes that have
been implicated -BTBD9 (DeAndrade et al., 2012) and MEIS1
(Salminen et al., 2018)-have already been mutated in mice,
resulting in alterations of sleep and motor activity that may be
relevant for RLS pathophysiology.
CONCLUSION
In conclusion, our results did not support the hypothesis that
mild hypoxia, alone or in combination with non-anemic iron
deficiency, is sufficient to elicit signs consistent with human RLS.
Other susceptibility factors not modeled in the present study,
such as brain iron deficiency or specific genetic risk factors, may
be key for the development of RLS.
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